Details for Patent: 10,603,290
✉ Email this page to a colleague
Which drugs does patent 10,603,290 protect, and when does it expire?
Patent 10,603,290 protects FINTEPLA and is included in one NDA.
Protection for FINTEPLA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has twenty-six patent family members in fourteen countries.
Summary for Patent: 10,603,290
Title: | Formulation for inhibiting formation of 5-HT.sub.2B agonists and methods of using same |
Abstract: | Drug combinations and their use are disclosed. A first drug is administered in combination with a second drug. The first drug such as fenfluramine is characterized by the formation of a metabolite including 5-HT.sub.2B agonists such as norfenfluramine with known adverse side effects. The second drug is in the form of a CYP inhibitor such as cannabidiol which modulates the formation of metabolite down thereby making the first drug safer. |
Inventor(s): | Farr; Stephen J. (Orinda, CA), Boyd; Brooks (Berkeley, CA) |
Assignee: | ZOGENIX INTERNATIONAL LIMITED (Berkshire, GB) |
Application Number: | 16/193,812 |
Patent Claim Types: see list of patent claims | Use; Formulation; |
Drugs Protected by US Patent 10,603,290
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ucb Inc | FINTEPLA | fenfluramine hydrochloride | SOLUTION;ORAL | 212102-001 | Jun 25, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,603,290
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2017315273 | ⤷ Try a Trial | |||
Australia | 2021204250 | ⤷ Try a Trial | |||
Australia | 2022279469 | ⤷ Try a Trial | |||
Canada | 3032996 | ⤷ Try a Trial | |||
China | 109689103 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |